118th Congress Health
S. 3220: To expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis
A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Kyrsten Sinema I-AZOriginal
- Markwayne Mullin R-OK
- John Hickenlooper D-CO
- Jeff Merkley D-OR
Who scored on this bill
- 1Mark Kelly SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Mark Kelly
- S. 5249: MORE American Fuel Act of 2026
- S. 3715: Chiricahua National Park Act
- S. 700: To require the Secretary of Agriculture to convey the Pleasant Valley Ranger District Administrative Site to Gila County, Arizona
- S. 2741: Legacy Mine Cleanup Act of 2025
- S. 2319: To designate the Federal building located at 300 West Congress Street in Tucson, Arizona, as the "Raul M. Grijalva Federal Building"
- S. 201: ACES Act of 2025
History
- Introduced in the Senate by Mark Kelly.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.